ANDROGENIX XL

DEAD

Serial Number

90895015

Owner

Centinela Medical Center of South Bay Inc.

First Use Date

Jun 11, 2020

Filing Date

Aug 21, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ANDROGENIX XL Trademark

Serial Number: 90895015 • Registration: 6999004

ANDROGENIX XL is a trademark filed by Centinela Medical Center of South Bay Inc. on August 21, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Centinela Medical Center of South Bay Inc. (6 trademarks)

15901 Hawthorne Blvd STE 450
Lawndale, CA 90260

Entity Type: 03

Legal Representation

Correspondence Address

CENTINELA MEDICAL CENTER OF SOUTH BAY INC.

15901 HAWTHORNE BLVD STE 450

LAWNDALE, CA 90260

UNITED STATES

Trademark Details

Filing Date

August 21, 2021

Registration Date

March 14, 2023

First Use Anywhere

June 11, 2020

First Use in Commerce

December 1, 2020

Published for Opposition

December 27, 2022

Cancellation Date

September 2, 2025

Goods & Services

Natural herbal supplements; Vitamin and mineral supplements

Filing History

CANCELLED SECTION 18-TOTAL

Sep 2, 2025 C18.

CANCELLATION TERMINATED NO. 999999

Sep 2, 2025 CANT

CANCELLATION GRANTED NO. 999999

Jul 3, 2025 CANG

CANCELLATION INSTITUTED NO. 999999

Apr 1, 2025 PETC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 14, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Mar 14, 2023 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 27, 2022 NPUB

PUBLISHED FOR OPPOSITION

Dec 27, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 7, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 18, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 17, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 17, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 17, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 17, 2022 GNRN

NON-FINAL ACTION E-MAILED

May 17, 2022 GNRT

NON-FINAL ACTION WRITTEN

May 17, 2022 CNRT

ASSIGNED TO EXAMINER

May 6, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 7, 2021 NWOS

NEW APPLICATION ENTERED

Aug 25, 2021 NWAP

Related Trademarks

More from this Owner

IMMUNOGENIX XL

PROSTAR XL

NEUROGENIX XL

ERECTAR XL

More in Same Class

72SEVENTYBIO